From Grief to Global Change: How the STARS Program Empowers Advocates to Drive Lung Cancer Research

… from a grieving family member into a passionate patient research advocate. Despite not having a background in healthcare or cancer research, Caleb was driven to make a difference. Together with … generating critical data that could shape future cancer research in Nigeria. Today, Caleb is part of the IASLC …

IASLC Launches Beta Version of VIKTOR

… In today’s digital landscape, clinicians and researchers in thoracic oncology can access a wealth of … of data—knowledge that is essential to advancing cancer research, developing new therapies, and ultimately saving … Virtual International Knowledgebase for Thoracic Oncology Research (VIKTOR)—a bioinformatics platform offering a unified …

IASLC Announces Partnerships to Spur Oncogene-Driven Lung Cancer Research, Address Global Challenges in Conquering Thoracic Cancers

Renowned Researcher Fred Hirsch Delivers 2022 Heine H. Hansen Award Lecture

… Dr. Hirsch’s significant contributions to international research and education. … Renowned Researcher Fred Hirsch Delivers 2022 Heine H. Hansen Award …

IASLC, LCRF Request Proposals for New Research Grant

Looking Ahead to the IASLC | ASCO 2025 North America Conference on Lung Cancer

… a unique opportunity for leading experts, clinicians, and researchers nationwide to come together for networking, education, and the presentation of the latest research in thoracic oncology. Christine Bestvina, MD … will be inspired to harness the power of AI to advance research further and faster. Don’t miss your chance to …

Pathology Researcher Keith Kerr Receives 2025 Heine H. Hansen Award

Patient Advocacy Groups Fund EGFR-related Research

… Patient Advocacy Groups Fund EGFR-related Research …

Cancer Research Innovator, Trailblazer, and Mentor Dr. Waun Ki Hong Dies

… Cancer Research Innovator, Trailblazer, and Mentor Dr. Waun Ki Hong …

Targeted Therapy Plus Immune Checkpoint Inhibitors: Research Opportunities, But No Improvement in Activity to Date

… Targeted Therapy Plus Immune Checkpoint Inhibitors: Research Opportunities, But No Improvement in Activity to Date …

IASLC Announces New JTO CRR Editor-in-Chief

In Brief for July 26, 2023

… to immunotherapy by Dr. Drew Pardoll. Lung Cancer Research Foundation announces appointment of new executive …